• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于间质光动力疗法中反应性单线态氧的异构优化算法。

A heterogeneous optimization algorithm for reacted singlet oxygen for interstitial PDT.

作者信息

Zhu Timothy C, Altschuler Martin D, Hu Yida, Wang Ken, Finlay Jarod C, Dimofte Andreea, Cengel Keith, Hahn Stephen M

机构信息

Department of Radiation Oncology, School of Medicine, University of Pennsylvania, Philadelphia, PA 19104.

出版信息

Proc SPIE Int Soc Opt Eng. 2010 Jan;7551. doi: 10.1117/12.842968.

DOI:10.1117/12.842968
PMID:25995533
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4435729/
Abstract

Singlet oxygen (O) is the major cytotoxic agent for type II photodynamic therapy (PDT). The production of O involves the complex reactions among light, oxygen molecule, and photosensitizer. From universal macroscopic kinetic equations which describe the photochemical processes of PDT, the reacted O concentration, [O], with cell target can be expressed in a form related to time integration of the product of O quantum yield and the PDT dose rate. The object of this study is to develop optimization procedures that account for the optical heterogeneity of the patient prostate, the tissue photosensitizer concentrations, and tissue oxygenation, thereby enable delivery of uniform reacted singlet oxygen to the gland. We use the heterogeneous optical properties measured for a patient prostate to calculate a light fluence kernel. Several methods are used to optimize the positions and intensities of CDFs. The Cimmino feasibility algorithm, which is fast, linear, and always converges reliably, is applied as a search tool to optimize the weights of the light sources at each step of the iterative selection. Maximum and minimum dose limits chosen for sample points in the prostate constrain the solution for the intensities of the linear light sources. The study shows that optimization of individual light source positions and intensities is feasible for the heterogeneous prostate during PDT. To study how different photosensitizer distributions as well as tissue oxygenation in the prostate affect optimization, comparisons of light fluence rate were made with measured distribution of photosensitizer in prostate under different tissue oxygenation conditions.

摘要

单线态氧(O)是II型光动力疗法(PDT)的主要细胞毒性剂。O的产生涉及光、氧分子和光敏剂之间的复杂反应。从描述PDT光化学过程的通用宏观动力学方程来看,与细胞靶点反应的O浓度[O]可以用一种与O量子产率和PDT剂量率乘积的时间积分相关的形式来表示。本研究的目的是开发优化程序,该程序要考虑患者前列腺的光学异质性、组织光敏剂浓度和组织氧合情况,从而能够向腺体输送均匀的反应单线态氧。我们使用为患者前列腺测量的非均匀光学特性来计算光通量核。采用多种方法来优化圆柱扩散光纤(CDF)的位置和强度。快速、线性且始终可靠收敛的奇米诺可行性算法被用作搜索工具,以在迭代选择的每个步骤中优化光源的权重。为前列腺中的采样点选择的最大和最小剂量限制约束了线性光源强度的解。研究表明,在PDT期间对异质性前列腺的单个光源位置和强度进行优化是可行的。为了研究前列腺中不同的光敏剂分布以及组织氧合如何影响优化,在不同组织氧合条件下,将光通量率与前列腺中光敏剂的测量分布进行了比较。

相似文献

1
A heterogeneous optimization algorithm for reacted singlet oxygen for interstitial PDT.一种用于间质光动力疗法中反应性单线态氧的异构优化算法。
Proc SPIE Int Soc Opt Eng. 2010 Jan;7551. doi: 10.1117/12.842968.
2
A heterogeneous algorithm for PDT dose optimization for prostate.一种用于前列腺光动力疗法(PDT)剂量优化的异构算法。
Proc SPIE Int Soc Opt Eng. 2009 Feb 18;7164:71640B. doi: 10.1117/12.809897.
3
Optimization of physiological parameter for macroscopic modeling of reacted singlet oxygen concentration in an model.在一个模型中对反应性单线态氧浓度宏观建模的生理参数优化。
Proc SPIE Int Soc Opt Eng. 2009 Feb 18;7164:71640O. doi: 10.1117/12.809024.
4
Optimization of light sources for prostate photodynamic therapy.前列腺光动力治疗光源的优化
Proc SPIE Int Soc Opt Eng. 2005 Apr 22;5689:186-197. doi: 10.1117/12.590343.
5
Explicit macroscopic singlet oxygen modeling for benzoporphyrin derivative monoacid ring A (BPD)-mediated photodynamic therapy.用于苯并卟啉衍生物单酸环A(BPD)介导的光动力疗法的显式宏观单线态氧建模
J Photochem Photobiol B. 2016 Nov;164:314-322. doi: 10.1016/j.jphotobiol.2016.09.031. Epub 2016 Sep 23.
6
Optimization of light source parameters in the photodynamic therapy of heterogeneous prostate.异质性前列腺光动力治疗中光源参数的优化
Phys Med Biol. 2008 Aug 7;53(15):4107-21. doi: 10.1088/0031-9155/53/15/007. Epub 2008 Jul 8.
7
In-vivo outcome study of HPPH mediated PDT using singlet oxygen explicit dosimetry (SOED).使用单线态氧显式剂量测定法(SOED)对HPPH介导的光动力疗法进行的体内结果研究。
Proc SPIE Int Soc Opt Eng. 2015 Mar 2;9308. doi: 10.1117/12.2076441.
8
singlet oxygen threshold doses for PDT.光动力疗法的单线态氧阈值剂量。
Photonics Lasers Med. 2015 Feb;4(1):59-71. doi: 10.1515/plm-2014-0037.
9
Integrated light dosimetry system for prostate photodynamic therapy.用于前列腺光动力治疗的集成光剂量测定系统。
Proc SPIE Int Soc Opt Eng. 2008 Jan 19;6845. doi: 10.1117/12.763806.
10
Comparison of singlet oxygen threshold dose for PDT.光动力疗法中单线态氧阈值剂量的比较。
Proc SPIE Int Soc Opt Eng. 2014 Feb 1;8931. doi: 10.1117/12.2039719.

引用本文的文献

1
Validation of combined Monte Carlo and photokinetic simulations for the outcome correlation analysis of benzoporphyrin derivative-mediated photodynamic therapy on mice.联合蒙特卡罗和光动力模拟方法验证对小鼠血啉甲醚介导光动力治疗效果的相关性分析。
J Biomed Opt. 2019 Mar;24(3):1-9. doi: 10.1117/1.JBO.24.3.035006.
2
Automatic interstitial photodynamic therapy planning via convex optimization.通过凸优化实现自动间质光动力治疗计划
Biomed Opt Express. 2018 Jan 30;9(2):898-920. doi: 10.1364/BOE.9.000898. eCollection 2018 Feb 1.

本文引用的文献

1
A fast heterogeneous algorithm for light fluence rate for prostate photodynamic therapy.一种用于前列腺光动力治疗光通量率的快速非均匀算法。
Proc SPIE Int Soc Opt Eng. 2010 Mar 2;7551. doi: 10.1117/12.843000.
2
Optimization of physiological parameter for macroscopic modeling of reacted singlet oxygen concentration in an model.在一个模型中对反应性单线态氧浓度宏观建模的生理参数优化。
Proc SPIE Int Soc Opt Eng. 2009 Feb 18;7164:71640O. doi: 10.1117/12.809024.
3
A heterogeneous algorithm for PDT dose optimization for prostate.一种用于前列腺光动力疗法(PDT)剂量优化的异构算法。
Proc SPIE Int Soc Opt Eng. 2009 Feb 18;7164:71640B. doi: 10.1117/12.809897.
4
Prostate PDT dosimetry.前列腺 PDT 剂量学。
Photodiagnosis Photodyn Ther. 2006 Dec;3(4):234-46. doi: 10.1016/j.pdpdt.2006.08.002. Epub 2006 Oct 19.
5
Explicit dosimetry for photodynamic therapy: macroscopic singlet oxygen modeling.光动力疗法的显式剂量学:宏观单线态氧建模。
J Biophotonics. 2010 Jun;3(5-6):304-18. doi: 10.1002/jbio.200900101.
6
Photodynamic therapy for prostate cancer--a review of current status and future promise.前列腺癌的光动力疗法——现状与未来展望综述
Nat Clin Pract Urol. 2009 Jan;6(1):18-30. doi: 10.1038/ncpuro1274.
7
The role of photodynamic therapy (PDT) physics.光动力疗法(PDT)物理学的作用。
Med Phys. 2008 Jul;35(7):3127-36. doi: 10.1118/1.2937440.
8
Motexafin lutetium-photodynamic therapy of prostate cancer: short- and long-term effects on prostate-specific antigen.莫替沙芬镥光动力疗法治疗前列腺癌:对前列腺特异性抗原的短期和长期影响
Clin Cancer Res. 2008 Aug 1;14(15):4869-76. doi: 10.1158/1078-0432.CCR-08-0317.
9
Optimization of light source parameters in the photodynamic therapy of heterogeneous prostate.异质性前列腺光动力治疗中光源参数的优化
Phys Med Biol. 2008 Aug 7;53(15):4107-21. doi: 10.1088/0031-9155/53/15/007. Epub 2008 Jul 8.
10
Determination of in vivo light fluence distribution in a heterogeneous prostate during photodynamic therapy.光动力疗法中异质性前列腺体内光通量分布的测定
Phys Med Biol. 2008 Apr 21;53(8):2103-14. doi: 10.1088/0031-9155/53/8/007. Epub 2008 Mar 27.